Full mouth ultrasonic debridement: protocollo terapeutico per la malattia parodontale applicato in un gruppo di pazienti con Sindrome di Down. Risultati a 1 anno.

The aim of this study was to test the therapeutic protocol for periodontal disease “Full mouth ultrasonic debridement” in Down syndrome patients, for promoting oral health and improving their quality of life limiting the invasiveness of treatment. 40 patients with Down syndrome and periodontal disease from mild to moderate were included in the study and divided into two groups. Patients in the test group were subjected to Full Mouth Ultrasonic Debridement; patients in the control group to conventional therapy Scaling and Root Plannig quadrant followed by monthly maintenance therapy. Medical history and periodontal data were collected (plaque index, bleeding index, probing depth) at time 0, 6 and 12 months after treatment. The FMPS FMBS respectively varied from baseline to 1 year in Test Group from 84% to 43% and from 82% to 34%; in Control Group from 86% to 46% and from 85% to 39%. The average probing depth varied in Test group from 6 ± 0.45 to 4.65 ± 0.57 at 12 months; in the group control from 5.98 ± 0.57 to 4.82 ± 0.64 at 12 months. None of the patients experienced acute problems during the time of the study. The average number of cartridges of anesthetic used for FMUD was 1.2, in the control group 4.5. The full mouth debridement Us has proved to be, in patients with Down syndrome, a valid therapeutic choice as equally effective, more efficient in terms of treatment sessions and less invasive in terms anesthetic used compared to the traditional approach providing the same results stability the over time. This study therefore proposes an alternative to conventional therapy for periodontal disease more easy to perform and less invasive in Down syndrome patients.